Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 25 to 29, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 25 to 29, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
New COVID-19 Variants May Weaken Efficacy of Vaccines
FRIDAY, Jan. 29, 2021 (HealthDay News) — The new coronavirus is mutating in an attempt to elude vaccines and treatments, putting a greater onus on Americans to get vaccinated and use social distancing measures to avoid infection, U.S. health officials said Friday.
SARS-CoV-2 Seroconversion Tied to Out-of-Hospital Sudden Deaths
FRIDAY, Jan. 29, 2021 (HealthDay News) — There was an association between geographic distribution of out-of-hospital sudden death and epidemiologic burden of severe acute respiratory syndrome coronavirus 2 in New York City during the first epidemic outbreak, according to a study published in the February issue of Heart Rhythm.
EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine
FRIDAY, Jan. 29, 2021 (HealthDay News) — European Union regulators have authorized the AstraZeneca COVID-19 vaccine for use in adults, CBS News reported Friday.
Nearly Half of U.S. Adults Want the COVID-19 Vaccine as Soon as Possible
FRIDAY, Jan. 29, 2021 (HealthDay News) — U.S. adults are increasingly eager to get the COVID-19 vaccine, according to survey results released by the Kaiser Family Foundation COVID-19 Vaccine Monitor.
J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
FRIDAY, Jan. 29, 2021 (HealthDay News) — Interim phase 3 data show that the COVID-19 vaccine developed by Janssen Pharmaceuticals of Johnson & Johnson is 66 percent effective in preventing moderate-to-severe COVID-19 in adults, the National Institutes of Health announced today.
COVID-19 Admissions, Fatalities Up for Pregnant Women
FRIDAY, Jan. 29, 2021 (HealthDay News) — Compared with similarly aged adults in Washington state, pregnant women have significantly higher COVID-19 hospitalization and case fatality rates, according to a study published online Jan. 26 in the American Journal of Obstetrics & Gynecology.
Schizophrenia Linked to Mortality in Adults With COVID-19
FRIDAY, Jan. 29, 2021 (HealthDay News) — A premorbid diagnosis of schizophrenia spectrum disorder is associated with mortality among adults with COVID-19, according to a study published online Jan. 27 in JAMA Psychiatry.
Guidance Issued for COVID-19 Vaccination of Cancer Patients
THURSDAY, Jan. 28, 2021 (HealthDay News) — In a new guidance statement from the National Comprehensive Cancer Network, recommendations are presented for COVID-19 vaccination of cancer patients.
Early Anticoagulation May Not Up Survival in Severe COVID-19
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
